Long-term follow-up of the West of Scotland Coronary Prevention Study [3]

New England Journal of Medicine

Volumn 358, Issue 2, 2008, Pages 194-

  DeFilippis, Andrew P ^a   Bansal, Sandeep ^a   Blumenthal, Roger S ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; PRAVASTATIN; HYPOCHOLESTEROLEMIC AGENT;

CLINICAL TRIAL; CORONARY ARTERY DISEASE; DISEASE CONTROL; FOLLOW UP; HUMAN; LETTER; LONG TERM CARE; PRIORITY JOURNAL; UNITED KINGDOM; HYPERCHOLESTEROLEMIA; MORTALITY; NOTE; STATISTICAL ANALYSIS;

ANTICHOLESTEREMIC AGENTS; CORONARY DISEASE; DATA INTERPRETATION, STATISTICAL; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; PRAVASTATIN;

EID: 38049141610     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: None     Document Type: Letter

References (1)

1. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III): final report. Bethesda, MD: National Heart, Lung, and Blood Institute, September 2002. (NIH publication no. 02-5215.)